StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Cerenome's EPS for the twelve months ending Sep 30, 2025 was -$48.94. For fiscal 2025 it was -$7.25. The highest annual figure on record is -$7.25 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.25–
FY2024Dec 31, 2024-$58.50–
FY2023Dec 31, 2023-$106.00–
FY2022Dec 31, 2022-$289.50–
FY2021Dec 31, 2021-$416.25–
FY2020Dec 31, 2020-$697.50–
FY2019Dec 31, 2019-$3101.25–
FY2018Dec 31, 2018-$32617.50–
FY2017Dec 31, 2017-$154312.50–
FY2016Dec 31, 2016-$240000.00–
FY2015Dec 31, 2015-$388125.00–
FY2014Dec 31, 2014-$1350000.00–
FY2013Dec 31, 2013-$1096875.00–
FY2012Dec 31, 2012-$1546875.00–
FY2011Dec 31, 2011-$1715625.00–
FY2010Dec 31, 2010-$1687500.00–
FY2009Dec 31, 2009-$1828125.00–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.31–
Q1 FY2026Mar 31, 2026-$1.05–
Q3 FY2025Sep 30, 2025-$1.00–
Q2 FY2025Jun 30, 2025-$0.16–
Q1 FY2025Mar 31, 2025-$29.86–
Q4 FY2024Dec 31, 2024-$17.92–
Q3 FY2024Sep 30, 2024-$9.25–
Q2 FY2024Jun 30, 2024-$17.75–
Q1 FY2024Mar 31, 2024-$18.75–
Q4 FY2023Dec 31, 2023-$21.17–
Q3 FY2023Sep 30, 2023-$25.00–
Q2 FY2023Jun 30, 2023-$14.75–
Q1 FY2023Mar 31, 2023-$51.75–
Q4 FY2022Dec 31, 2022-$63.05–
Q3 FY2022Sep 30, 2022-$71.25–
Q2 FY2022Jun 30, 2022-$89.00–
Q1 FY2022Mar 31, 2022-$71.25–
Q4 FY2021Dec 31, 2021-$100.70–
Q3 FY2021Sep 30, 2021-$105.00–
Q2 FY2021Jun 30, 2021-$93.75–
Q1 FY2021Mar 31, 2021-$123.75–
Q4 FY2020Dec 31, 2020-$250.45–
Q3 FY2020Sep 30, 2020-$146.25–
Q2 FY2020Jun 30, 2020-$168.75–
Q1 FY2020Mar 31, 2020-$105.00–
Q3 FY2019Sep 30, 2019-$11.25–
Q2 FY2019Jun 30, 2019-$7751.25–
Q1 FY2019Mar 31, 2019-$3345.00–
Q4 FY2018Dec 31, 2018-$3021.62–
Q1 FY2018Mar 31, 2018-$13687.50–
Q4 FY2017Dec 31, 2017-$37500.00–
Q3 FY2017Sep 30, 2017-$26062.50–
Q2 FY2017Jun 30, 2017-$36375.00–
Q1 FY2017Mar 31, 2017-$61875.00–
Q4 FY2016Dec 31, 2016-$45000.00–
Q3 FY2016Sep 30, 2016-$48750.00–
Q2 FY2016Jun 30, 2016-$80625.00–

More Cerenome figures

See a number that looks wrong?